Chad F Claus, DO

Biographical Statement

Following residency, Dr. Claus went on to complete his Neuroendovascular fellowship at the University of Alabama, Birmingham with focus on complex cerebrovascular diseases such as aneurysms, arteriovenous malformations (AVMs), arteriovenous fistulas, extracranial carotid disease, and ischemic stroke. During his training, Dr. Claus performed over 2000 Endovascular/Cerebrovascular surgeries, including complex aneurysms and arteriovenous malformations. Dr. Claus also performed well over 1000 minimally invasive spine (MIS) surgeries, including complex multi-level and revision fusions as well as non-fusion or motion-preservation surgeries. He has particular interest in treatment and management of extracranial cerebrovascular occlusive disease such as carotid stenosis as well as acute ischemic stroke.

Care Philosophy

I am a fellowship trained neurosurgeon who specializes in cerebrovascular & endovascular surgery of the brain and spine with additional subspecialty training in minimally invasive and complex spine surgery. I earned my bachelor’s degree in biology & Biochemistry from the University of Nevada, Las Vegas. I then went on to complete my medical degree at Western University of Health Sciences. I completed my training in Neurosurgery at the rigorous Michigan State University with heavy focus on cerebrovascular surgery and minimally invasive & robotic spine surgery.

Research Interests

• Spine clinical conditions such as cervical stenosis, lumbar stenosis, etc.
• Aneurysms
• Arteriovenous malformations (AVMs)
• Arteriovenous fistulas
• Extracranial carotid disease
• Ischemic stroke
• Treatment and management of extracranial cerebrovascular occlusive disease
• Carotid Stenosis
• Acute Ischemic stroke
• Minimally invasive & robotic spine surgery

Awards & Honors

• Ascension Providence Hospital Research Day, 2023. 1st place poster presentation.
  • Outcomes in Patients with Non-Segmental Versus Segmental Instrumentation in Minimally Invasive Transforaminal Lumbar Interbody Fusion: A Longitudinal Comparative Cohort Study
• Ascension Providence Hospital Research Day, 2023. 3rd place poster presentation.
  • Age as a Predictor for Patient-Reported Outcomes in Anterior Cervical Discectomy and Fusion: Analysis from the Michigan Spine Surgery Improvement Collaborative (MSSIC)
• The Spine Journal’s 2021 Outstanding Paper Award, 2021. NASS and The Spine Journal recognizing excellence in unpublished spine care research
  • The Effect of Ketorolac on Posterior Minimally Invasive Lumbar Spinal Fusion: An Interim Analysis from a Randomized, Double-Blinded, Placebo-Controlled Trial
• Charles Kuntz IV Scholar Award, 2021. AANS/CNS Joint Section on Disorders of the Spine and Peripheral Nerves Annual Meeting
  • The Effect of Morbid Obesity on Complications, Readmission, and Patient-Reported Outcomes following Minimally Invasive Transforaminal Lumbar Interbody Fusion: An Inverse Propensity Score-Weighted Analysis
• Ascension Providence Hospital Research Day, 2021. 1st place oral presentation
  • The Effect of Morbid Obesity on Complications, Readmission, and Patient-Reported Outcomes following Minimally Invasive Transforaminal Lumbar Interbody Fusion: An Inverse Propensity Score-Weighted Analysis
• Ascension Providence Hospital Research Day, 2021. 2nd place poster presentation
  • Treatment of Refractory Cerebral Vasospasm Using a Microwire-assisted Angioplasty: The “J”-Plasty
• The Mayfield Award, 2019.
  • AANS/CNS Joint Section on Disorders of the Spine and Peripheral Nerves most outstanding manuscripts detailing a clinical investigation in the area of spinal or peripheral nerve disorders
  • Fusion and Opioid-sparing with the Use of Ketorolac in Posterior Thoracolumbar Spinal Fusions: A Prospective Double-blinded Randomized Placebo-Controlled Trial
• Southeast Michigan Center for Medical Education research forum, 2019. 3rd place oral presentation
  • Fusion and Opioid-sparing with the Use of Ketorolac in Posterior Thoracolumbar Spinal Fusions: A Prospective Double-blinded Randomized Placebo-Controlled Trial
• Ascension Providence Hospital Research Day, 2019. 1st place oral presentation
  • Fusion and Opioid-sparing with the Use of Ketorolac in Posterior Thoracolumbar Spinal Fusions: A Prospective Double-blinded Randomized Placebo-Controlled Trial
• Student DO Researcher of the Year Award, 2014 Student Summer Research Grant Fellowship, 2013
  • Characterization of SK2/3 channels in maternally deleted Ube3a mice